Recursion Pharmaceuticals, Inc. (BMV:RXRX)
67.00
+4.00 (6.35%)
At close: Feb 9, 2026
-66.50% (1Y)
| Market Cap | 35.60B -39.1% |
| Revenue (ttm) | 801.35M -33.0% |
| Net Income | -13.12B |
| EPS | -32.72 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20 |
| Average Volume | 2,214 |
| Open | 67.00 |
| Previous Close | 63.00 |
| Day's Range | 67.00 - 67.00 |
| 52-Week Range | 63.00 - 219.00 |
| Beta | n/a |
| RSI | 37.19 |
| Earnings Date | Feb 27, 2026 |